Cargando…
Amber photobiomodulation versus tranexamic acid for the treatment of melasma: protocol for a double-blind, randomised controlled trial
INTRODUCTION: Photobiomodulation (PBM) has been suggested as an alternative treatment for melasma. In vitro studies have shown PBM with amber light inhibits the tyrosinase enzyme, induces autophagy and reduces the melanin content, but randomised controlled clinical trials are still needed. This stud...
Autores principales: | Galache, Thais Rodrigues, Galache, Marcelo, Sena, Michelle Mota, Pavani, Christiane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364183/ https://www.ncbi.nlm.nih.gov/pubmed/37479524 http://dx.doi.org/10.1136/bmjopen-2023-073568 |
Ejemplares similares
-
Comparison of the Efficacy of Intralesional Tranexamic Acid Versus Topical 4% Hydroquinone in Treating Melasma
por: Mushtaq, Shigref, et al.
Publicado: (2022) -
Efficacy of phototherapy to treat facial ageing when using a red versus an amber LED: a protocol for a randomised controlled trial
por: Rocha Mota, Lidiane, et al.
Publicado: (2018) -
Comparative Study of Combination of Oral Tranexamic Acid With Modified Kligman’s Formula Versus Oral Tranexamic Acid With Azelaic Acid 15% in the Treatment of Melasma
por: Singh, Riddhima, et al.
Publicado: (2023) -
Melasma: A Condition of Asian Skin
por: Wu, Michelle X, et al.
Publicado: (2021) -
Randomised, Placebo-Controlled, Double-Blind Study of Oral Tranexamic Acid in the Treatment of Moderate-to-Severe Melasma in an Australian Cohort
por: Bala, Harini Rajgopal, et al.
Publicado: (2022)